"The project has the potential to significantly improve the health and well-being of older people with subclinical hypothyroidism"
- Professor David Stott from the University of Glasgow
TRUST Thyroid trial

Collaboration TRUST and IEMO 80+

By signing the Memorandum of Understanding, the collaboration between the IEMO 80+ Thyroid Trial and the TRUST Thyroid Trial was officially confirmed on November 4th in Glasgow. Two studies with one research question: what is the safety and efficacy of thyroid hormone supplementation in older adults with subclinical hypothyroidism?

Dr. Simon Mooijaart (IEMO) and prof. David Stott (TRUST)

Whereas the TRUST Thyroid Trial will be performed in four universities throughout Europe (Glasgow, Bern, Cork and Leiden) among 3000 participants aged 65 or older, the IEMO 80+ Thyroid Trial will be performed in three University Medical Centers in the Netherlands among 450 participants aged 80 years and older. Both trials use identical research infrastructures and share local procedures, which enhances the efficiency to perform the trials. Effects for the 80+ participants of both studies allows for giving a specific advice regarding the treatment of subclinical hypothyroidism in the 80+ population.
Both trials have started recruiting participants in 2013.

For more information about the IEMO 80+ Thyroid Trial, please visit: www.iemoschildklierstudie.nl.